Picture of Climb Bio logo

CLYM — Climb Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Eliem Therapeutics Provides Update On Pipeline Progress

Oct 5 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS PROVIDES UPDATE ON PIPELINE PROGRESS
    * ELIEM THERAPEUTICS INC - COMPANY TO INITIATE PHASE 2A
TRIAL IN
MAJOR DEPRESSIVE DISORDER (MDD) IN Q1 OF 2023
    * ELIEM THERAPEUTICS INC - PROGRESSING INTO IND-ENABLING
STUDIES
FOR TWO KV7 PRE-CANDIDATES

Source text for Eikon:  ID:nGNX8mgNCf 
Further company coverage:  ELYM.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Climb Bio

See all news